Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element - PubMed (original) (raw)
. 2000 Jul 14;275(28):21041-7.
doi: 10.1074/jbc.M910165199.
Affiliations
- PMID: 10766763
- DOI: 10.1074/jbc.M910165199
Free article
Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element
F Pagani et al. J Biol Chem. 2000.
Free article
Abstract
In monosymptomatic forms of cystic fibrosis such as congenital bilateral absence of vas deferens, variations in the TG(m) and T(n) polymorphic repeats at the 3' end of intron 8 of the cystic fibrosis transmembrane regulator (CFTR) gene are associated with the alternative splicing of exon 9, which results in a nonfunctional CFTR protein. Using a minigene model system, we have previously shown a direct relationship between the TG(m)T(n) polymorphism and exon 9 splicing. We have now evaluated the role of splicing factors in the regulation of the alternative splicing of this exon. Serine-arginine-rich proteins and the heterogeneous nuclear ribonucleoprotein A1 induced exon skipping in the human gene but not in its mouse counterpart. The effect of these proteins on exon 9 exclusion was strictly dependent on the composition of the TG(m) and T(n) polymorphic repeats. The comparative and functional analysis of the human and mouse CFTR genes showed that a region of about 150 nucleotides, present only in the human intron 9, mediates the exon 9 splicing inhibition in association with exonic regulatory elements. This region, defined as the CFTR exon 9 intronic splicing silencer, is a target for serine-arginine-rich protein interactions. Thus, the nonevolutionary conserved CFTR exon 9 alternative splicing is modulated by the TG(m) and T(n) polymorphism at the 3' splice region, enhancer and silencer exonic elements, and the intronic splicing silencer in the proximal 5' intronic region. Tissue levels and individual variability of splicing factors would determine the penetrance of the TG(m)T(n) locus in monosymptomatic forms of cystic fibrosis.
Similar articles
- An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E, Buratti E, Stuani C, Baralle FE, Pagani F. Zuccato E, et al. J Biol Chem. 2004 Apr 23;279(17):16980-8. doi: 10.1074/jbc.M313439200. Epub 2004 Feb 13. J Biol Chem. 2004. PMID: 14966131 - Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
Niksic M, Romano M, Buratti E, Pagani F, Baralle FE. Niksic M, et al. Hum Mol Genet. 1999 Dec;8(13):2339-49. doi: 10.1093/hmg/8.13.2339. Hum Mol Genet. 1999. PMID: 10556281 - A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Disset A, Michot C, Harris A, Buratti E, Claustres M, Tuffery-Giraud S. Disset A, et al. Hum Mutat. 2005 Jan;25(1):72-81. doi: 10.1002/humu.20115. Hum Mutat. 2005. PMID: 15580565 - Molecular pathology of the CFTR locus in male infertility.
Claustres M. Claustres M. Reprod Biomed Online. 2005 Jan;10(1):14-41. doi: 10.1016/s1472-6483(10)60801-2. Reprod Biomed Online. 2005. PMID: 15705292 Review. - Splicing mutations in the CFTR gene as therapeutic targets.
Deletang K, Taulan-Cadars M. Deletang K, et al. Gene Ther. 2022 Aug;29(7-8):399-406. doi: 10.1038/s41434-022-00347-0. Epub 2022 Jun 2. Gene Ther. 2022. PMID: 35650428 Free PMC article. Review.
Cited by
- Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
Cuajungco MP, Leyne M, Mull J, Gill SP, Lu W, Zagzag D, Axelrod FB, Maayan C, Gusella JF, Slaugenhaupt SA. Cuajungco MP, et al. Am J Hum Genet. 2003 Mar;72(3):749-58. doi: 10.1086/368263. Epub 2003 Feb 6. Am J Hum Genet. 2003. PMID: 12577200 Free PMC article. - Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis.
Lu L, Zheng L, Si Y, Luo W, Dujardin G, Kwan T, Potochick NR, Thompson SR, Schneider DA, King PH. Lu L, et al. J Biol Chem. 2014 Nov 14;289(46):31792-31804. doi: 10.1074/jbc.M114.573246. Epub 2014 Sep 19. J Biol Chem. 2014. PMID: 25239623 Free PMC article. - Short linear motif acquisition, exon formation and alternative splicing determine a pathway to diversity for NCoR-family co-repressors.
Short S, Peterkin T, Guille M, Patient R, Sharpe C. Short S, et al. Open Biol. 2015 Aug;5(8):150063. doi: 10.1098/rsob.150063. Open Biol. 2015. PMID: 26289800 Free PMC article. - An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis.
Di Lullo AM, Scorza M, Amato F, Comegna M, Raia V, Maiuri L, Ilardi G, Cantone E, Castaldo G, Iengo M. Di Lullo AM, et al. Acta Otorhinolaryngol Ital. 2017 Jun;37(3):207-213. doi: 10.14639/0392-100X-1328. Acta Otorhinolaryngol Ital. 2017. PMID: 27897275 Free PMC article. - Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia*.
Baughn JM, Quasney MW, Simpson P, Merchant D, Li SH, Levy H, Dahmer MK. Baughn JM, et al. Crit Care Med. 2012 Nov;40(11):3042-9. doi: 10.1097/CCM.0b013e31825d8f73. Crit Care Med. 2012. PMID: 22890249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous